VanEck Associates
NOVT icon

VanEck Associates’s Novanta NOVT Stock Holding History

VanEck Associates’s Portfolio NOVT Stock Details NOVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
8,917
+2,710
+44% +$392K ﹤0.01% 1086
2026
Q1 		$733K Buy
6,207
+2,736
+79% +$359K ﹤0.01% 1129
2025
Q4 		$413K Buy
3,471
+1,844
+113% +$210K ﹤0.01% 1204
2025
Q3 		$163K Buy
1,627
+239
+17% +$28.5K ﹤0.01% 1291
2025
Q2 		$179K Buy
1,388
+391
+39% +$47.6K ﹤0.01% 1260
2025
Q1 		$127K Buy
997
+348
+54% +$50K ﹤0.01% 1262
2024
Q4 		$99K Sell
649
-314
-33% -$53.2K ﹤0.01% 1271
2024
Q3 		$166K Buy
963
+213
+28% +$37K ﹤0.01% 1209
2024
Q2 		$122K Buy
750
+242
+48% +$39.3K ﹤0.01% 1240
2024
Q1 		$89K Buy
508
+282
+125% +$46.3K ﹤0.01% 1240
2023
Q4 		$38K Buy
226
+41
+22% +$5.98K ﹤0.01% 1303
2023
Q3 		$27K Hold
185
– – ﹤0.01% 1322
2023
Q2 		$34K Buy
+185
New +$30.3K ﹤0.01% 1323

Other funds holding NOVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

VanEck Associates's NOVT Position: Q2 2026 in Review

VanEck Associates increased its Novanta (NOVT) stake by 44% in Q2 2026, buying an estimated $392K and bringing the position to 8,917 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

VanEck Associates first reported a position in NOVT in Q2 2023 and has held it in 13 quarters since. 389 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.

  • VanEck Associates held 8,917 shares of Novanta worth $1.45M as of Q2 2026.
  • VanEck Associates bought 2,710 Novanta shares in Q2 2026, an estimated $392K.
  • Novanta made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1086 holding.
  • VanEck Associates first reported a position in Novanta in Q2 2023 and has held it in 13 quarters since.
  • 389 funds tracked by Wall St. Rank held Novanta as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.